Toxicity in the era of immune checkpoint inhibitor therapy.

Autor: Keam S; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Turner N; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Kugeratski FG; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Rico R; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Colunga-Minutti J; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; The University of Texas MD Anderson Cancer Center University of Texas Health (UTHealth) Houston Graduate School of Biomedical Sciences (GSBS), Houston, TX, United States., Poojary R; Independence High School, Frisco, TX, United States., Alekseev S; College of Sciences, The University of Texas at San Antonio, San Antonio, TX, United States.; The Cancer Prevention and Research Institute of Texas (CPRIT)-CURE Summer Undergraduate Program, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Patel AB; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Li YJ; Department of General Internal Medicine, Section of Rheumatology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Sheshadri A; Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Loghin ME; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Woodman K; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Aaroe AE; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Hamidi S; Department of Endocrine Neoplasia and HD, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Iyer PC; Department of Endocrine Neoplasia and HD, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Palaskas NL; Department of Cardiology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Wang Y; Department of Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Nurieva R; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; The University of Texas MD Anderson Cancer Center University of Texas Health (UTHealth) Houston Graduate School of Biomedical Sciences (GSBS), Houston, TX, United States.

Publikováno v: Frontiers in immunology [Front Immunol] 2024 Aug 23; Vol. 15, pp. 1447021. Date of Electronic Publication: 2024 Aug 23 (Print Publication: 2024).

Neurologic Complications of Cancer Immunotherapy.

Autor: Alsalem AN; Division of Neurology, University of British Columbia, Vancouver, BC V6T 2B5, Canada., Scarffe LA; Division of Neurology, University of British Columbia, Vancouver, BC V6T 2B5, Canada., Briemberg HR; Division of Neurology, University of British Columbia, Vancouver, BC V6T 2B5, Canada., Aaroe AE; Department of Neuro-Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Harrison RA; Division of Neurology, University of British Columbia, Vancouver, BC V6T 2B5, Canada.; Division of Medical Oncology, BC Cancer, University of British Columbia, Vancouver, BC V5Z 4E6, Canada.

Publikováno v: Current oncology (Toronto, Ont.) [Curr Oncol] 2023 Jun 19; Vol. 30 (6), pp. 5876-5897. Date of Electronic Publication: 2023 Jun 19.

Pearls & Oy-sters: Primary Pineal Melanoma With Leptomeningeal Carcinomatosis.

Autor: Aaroe AE; From the Departments of Neuro-Oncology (A.E.A., R.A.H.) and Melanoma Medical Oncology (I.C.G.O.), Division of Cancer Medicine, Departments of Head and Neck Surgery (N.A.-Z., M.-E.N.) and Neurosurgery (S.D.F.), Division of Surgery, Department of Neuroradiology, Division of Diagnostic Imaging (D.K.), Department of Radiation Oncology, Division of Radiation Oncology (C.W.), and Department of Pathology, Division of Pathology and Laboratory Medicine (G.F.), MD Anderson Cancer Center, Houston, TX. AAaroe@mdanderson.org., Glitza Oliva IC; From the Departments of Neuro-Oncology (A.E.A., R.A.H.) and Melanoma Medical Oncology (I.C.G.O.), Division of Cancer Medicine, Departments of Head and Neck Surgery (N.A.-Z., M.-E.N.) and Neurosurgery (S.D.F.), Division of Surgery, Department of Neuroradiology, Division of Diagnostic Imaging (D.K.), Department of Radiation Oncology, Division of Radiation Oncology (C.W.), and Department of Pathology, Division of Pathology and Laboratory Medicine (G.F.), MD Anderson Cancer Center, Houston, TX., Al-Zubidi N; From the Departments of Neuro-Oncology (A.E.A., R.A.H.) and Melanoma Medical Oncology (I.C.G.O.), Division of Cancer Medicine, Departments of Head and Neck Surgery (N.A.-Z., M.-E.N.) and Neurosurgery (S.D.F.), Division of Surgery, Department of Neuroradiology, Division of Diagnostic Imaging (D.K.), Department of Radiation Oncology, Division of Radiation Oncology (C.W.), and Department of Pathology, Division of Pathology and Laboratory Medicine (G.F.), MD Anderson Cancer Center, Houston, TX., Nader ME; From the Departments of Neuro-Oncology (A.E.A., R.A.H.) and Melanoma Medical Oncology (I.C.G.O.), Division of Cancer Medicine, Departments of Head and Neck Surgery (N.A.-Z., M.-E.N.) and Neurosurgery (S.D.F.), Division of Surgery, Department of Neuroradiology, Division of Diagnostic Imaging (D.K.), Department of Radiation Oncology, Division of Radiation Oncology (C.W.), and Department of Pathology, Division of Pathology and Laboratory Medicine (G.F.), MD Anderson Cancer Center, Houston, TX., Kaya D; From the Departments of Neuro-Oncology (A.E.A., R.A.H.) and Melanoma Medical Oncology (I.C.G.O.), Division of Cancer Medicine, Departments of Head and Neck Surgery (N.A.-Z., M.-E.N.) and Neurosurgery (S.D.F.), Division of Surgery, Department of Neuroradiology, Division of Diagnostic Imaging (D.K.), Department of Radiation Oncology, Division of Radiation Oncology (C.W.), and Department of Pathology, Division of Pathology and Laboratory Medicine (G.F.), MD Anderson Cancer Center, Houston, TX., Ferguson SD; From the Departments of Neuro-Oncology (A.E.A., R.A.H.) and Melanoma Medical Oncology (I.C.G.O.), Division of Cancer Medicine, Departments of Head and Neck Surgery (N.A.-Z., M.-E.N.) and Neurosurgery (S.D.F.), Division of Surgery, Department of Neuroradiology, Division of Diagnostic Imaging (D.K.), Department of Radiation Oncology, Division of Radiation Oncology (C.W.), and Department of Pathology, Division of Pathology and Laboratory Medicine (G.F.), MD Anderson Cancer Center, Houston, TX., Wang C; From the Departments of Neuro-Oncology (A.E.A., R.A.H.) and Melanoma Medical Oncology (I.C.G.O.), Division of Cancer Medicine, Departments of Head and Neck Surgery (N.A.-Z., M.-E.N.) and Neurosurgery (S.D.F.), Division of Surgery, Department of Neuroradiology, Division of Diagnostic Imaging (D.K.), Department of Radiation Oncology, Division of Radiation Oncology (C.W.), and Department of Pathology, Division of Pathology and Laboratory Medicine (G.F.), MD Anderson Cancer Center, Houston, TX., Fuller G; From the Departments of Neuro-Oncology (A.E.A., R.A.H.) and Melanoma Medical Oncology (I.C.G.O.), Division of Cancer Medicine, Departments of Head and Neck Surgery (N.A.-Z., M.-E.N.) and Neurosurgery (S.D.F.), Division of Surgery, Department of Neuroradiology, Division of Diagnostic Imaging (D.K.), Department of Radiation Oncology, Division of Radiation Oncology (C.W.), and Department of Pathology, Division of Pathology and Laboratory Medicine (G.F.), MD Anderson Cancer Center, Houston, TX., Harrison RA; From the Departments of Neuro-Oncology (A.E.A., R.A.H.) and Melanoma Medical Oncology (I.C.G.O.), Division of Cancer Medicine, Departments of Head and Neck Surgery (N.A.-Z., M.-E.N.) and Neurosurgery (S.D.F.), Division of Surgery, Department of Neuroradiology, Division of Diagnostic Imaging (D.K.), Department of Radiation Oncology, Division of Radiation Oncology (C.W.), and Department of Pathology, Division of Pathology and Laboratory Medicine (G.F.), MD Anderson Cancer Center, Houston, TX.

Publikováno v: Neurology [Neurology] 2021 Aug 03; Vol. 97 (5), pp. 248-250. Date of Electronic Publication: 2021 Apr 30.

Associations between cerebrovascular risk factors and parkinson disease.

Autor: Kummer BR; Clinical and Translational Neuroscience Unit, Feil Family Brain and Mind Research Institute, and Department of Neurology, Weill Cornell Medicine, New York, NY., Diaz I; Division of Biostatistics and Epidemiology, Department of Healthcare Policy and Research, Weill Cornell Medicine, New York, NY., Wu X; Division of Biostatistics and Epidemiology, Department of Healthcare Policy and Research, Weill Cornell Medicine, New York, NY., Aaroe AE; Clinical and Translational Neuroscience Unit, Feil Family Brain and Mind Research Institute, and Department of Neurology, Weill Cornell Medicine, New York, NY., Chen ML; Clinical and Translational Neuroscience Unit, Feil Family Brain and Mind Research Institute, and Department of Neurology, Weill Cornell Medicine, New York, NY., Iadecola C; Clinical and Translational Neuroscience Unit, Feil Family Brain and Mind Research Institute, and Department of Neurology, Weill Cornell Medicine, New York, NY., Kamel H; Clinical and Translational Neuroscience Unit, Feil Family Brain and Mind Research Institute, and Department of Neurology, Weill Cornell Medicine, New York, NY., Navi BB; Clinical and Translational Neuroscience Unit, Feil Family Brain and Mind Research Institute, and Department of Neurology, Weill Cornell Medicine, New York, NY.

Publikováno v: Annals of neurology [Ann Neurol] 2019 Oct; Vol. 86 (4), pp. 572-581. Date of Electronic Publication: 2019 Aug 29.